Naples Laser & Skin

Components	Semaglutide Glycine
Semaglutide class	Synthetic GLP-1 receptor agonist — 31-amino-acid fatty-acid modified peptide analog
Semaglutide MW	≈ 4,113.6 g/mol
Glycine class	Non-essential amino acid — naturally occurring in the body; used here as a stabilizing excipient and physiologically compatible carrier
Form	2 mL multi-dose vial 4 mL multi-dose vial Subcutaneous injection Compounded formulation; vial size accommodates varying dose escalation schedules
Half-life	≈ 7 days (semaglutide — supports once-weekly dosing)
Rx status	Prescription only — treatment appropriateness determined by licensed provider based on individual health history and goals
Origin	Semaglutide developed by Novo Nordisk; engineered from native GLP-1 with fatty acid modification enabling albumin-binding and extended circulation

HOW IT WORKS

Semaglutide works by activating GLP-1 receptors, which are involved in appetite regulation, digestion, insulin signaling, and blood-sugar control.

By acting on these pathways, semaglutide can help reduce hunger, increase feelings of fullness, decrease food cravings, and make portion control easier, supporting meaningful weight-management progress when paired with healthy nutrition and lifestyle habits.

Glycine is an amino acid involved in normal cellular and metabolic processes and is included as part of the compounded formulation.

WHAT TO EXPECT

As treatment begins, patients may notice:

• Less hunger between meals

• Feeling satisfied with smaller portions

• Fewer cravings

• Less food-focused thinking or “food noise”

• Greater control around eating

• Gradual weight-management progress over time

The early stage of treatment is often about building consistency and finding the dose that feels effective and comfortable.

BEFORE YOU START

Before starting Semaglutide + Glycine, your medical prescriber will review your health history, current medications, previous weight-management treatments, and treatment goals to determine whether this treatment is appropriate for you.

Be sure to discuss any history of pancreatitis, gallbladder problems, significant digestive conditions, kidney concerns, diabetes-related eye complications, or thyroid cancer, including a personal or family history of medullary thyroid carcinoma or MEN2.

Let your provider know if you are pregnant, breastfeeding, planning pregnancy, or taking medications that affect blood sugar or appetite.

Your dose may be increased gradually based on your tolerance, response, and progress.

Prescription required.